spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

doi: 10.1242/10.1242/jcs.00036


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Engling, A.
Right arrow Articles by Nickel, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Engling, A.
Right arrow Articles by Nickel, W.
Journal of Cell Science 115, 3619-3631 (2002)
© 2002 The Company of Biologists Limited
DOI: 10.1242/jcs.00036


Research Article

Biosynthetic FGF-2 is targeted to non-lipid raft microdomains following translocation to the extracellular surface of CHO cells

André Engling*,1, Rafael Backhaus*,1, Carolin Stegmayer1, Christoph Zehe1, Claudia Seelenmeyer1, Angelika Kehlenbach2, Blanche Schwappach2, Sabine Wegehingel1 and Walter Nickel1,{ddagger}

1 Biochemie-Zentrum Heidelberg (BZH), Im Neuenheimer Feld 328, 69120 Heidelberg, Germany
2 Zentrum für Molekulare Biologie Heidelberg (ZMBH), Im Neuenheimer Feld 282, 69120 Heidelberg, Germany

{ddagger} Author for correspondence (e-mail: walter.nickel{at}urz.uni-heidelberg.de)

Accepted 25 June 2002

Basic fibroblast growth factor (FGF-2) is a secretory protein that lacks a signal peptide. Consistently, FGF-2 has been shown to be secreted by an ER-Golgi-independent mechanism; however, the machinery mediating this process remains to be established at the molecular level. Here we introduce a novel experimental system based on flow cytometry that allows the quantitative assessment of non-classical FGF-2 secretion in living cells. Stable cell lines have been created by retroviral transduction that express various kinds of FGF-2-GFP fusion proteins in a doxicyclin-dependent manner. Following induction of protein expression, biosynthetic FGF-2-GFP is shown to translocate to the outer surface of the plasma membrane as determined by both fluorescence activated cell sorting (FACS) and confocal microscopy. Both N- and C-terminal GFP tagging of FGF-2 is compatible with FGF-2 export, which is shown to occur in a controlled fashion rather than through unspecific release. The experimental system described has strong implications for the identification of both FGF-2 secretion inhibitors and molecular components involved in FGF-2 secretion.

In the second part of this study we made use of the FGF-2 export system described to analyze the fate of biosynthetic FGF-2-GFP following export to the extracellular space. We find that secreted FGF-2 fusion proteins accumulate in large heparan sulfate proteoglycan (HSPG)-containing protein clusters on the extracellular surface of the plasma membrane. These microdomains are shown to be distinct from caveolae-like lipid rafts known to play a role in FGF-2-mediated signal transduction. Since CHO cells lack FGF high-affinity receptors (FGFRs), it can be concluded that FGFRs mediate the targeting of FGF-2 to lipid rafts. Consistently, FGF-2-GFP-secreting CHO cells do not exhibit increased proliferation activity. Externalization and deposition of biosynthetic FGF-2 in HSPG-containing protein clusters are independent processes, as a soluble secreted intermediate was demonstrated. The balance between intracellular FGF-2 and HSPG-bound secreted FGF-2 is shown not to be controlled by the availability of cell surface HSPGs, indicating that the FGF-2 secretion machinery itself is rate-limiting.

Key words: Non-conventional protein secretion, Non-classical protein export, Membrane translocation, Extracellular FGF-2, FGF-2 signalling, FGF-2 microdomains




This article has been cited by other articles:


Home page
J. Cell Sci.Home page
S. Tournaviti, S. Hannemann, S. Terjung, T. M. Kitzing, C. Stegmayer, J. Ritzerfeld, P. Walther, R. Grosse, W. Nickel, and O. T. Fackler
SH4-domain-induced plasma membrane dynamization promotes bleb-associated cell motility
J. Cell Sci., November 1, 2007; 120(21): 3820 - 3829.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
W. Nickel
Unconventional secretion: an extracellular trap for export of fibroblast growth factor 2
J. Cell Sci., July 15, 2007; 120(14): 2295 - 2299.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Zehe, A. Engling, S. Wegehingel, T. Schafer, and W. Nickel
Cell-surface heparan sulfate proteoglycans are essential components of the unconventional export machinery of FGF-2
PNAS, October 17, 2006; 103(42): 15479 - 15484.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
M. A. Lynes, K. Zaffuto, D. W. Unfricht, G. Marusov, J. S. Samson, and X. Yin
The physiological roles of extracellular metallothionein.
Experimental Biology and Medicine, October 1, 2006; 231(9): 1548 - 1554.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
C. Seelenmeyer, S. Wegehingel, I. Tews, M. Kunzler, M. Aebi, and W. Nickel
Cell surface counter receptors are essential components of the unconventional export machinery of galectin-1
J. Cell Biol., October 24, 2005; 171(2): 373 - 381.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
C. Stegmayer, A. Kehlenbach, S. Tournaviti, S. Wegehingel, C. Zehe, P. Denny, D. F. Smith, B. Schwappach, and W. Nickel
Direct transport across the plasma membrane of mammalian cells of Leishmania HASPB as revealed by a CHO export mutant
J. Cell Sci., February 1, 2005; 118(3): 517 - 527.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
R. Backhaus, C. Zehe, S. Wegehingel, A. Kehlenbach, B. Schwappach, and W. Nickel
Unconventional protein secretion: membrane translocation of FGF-2 does not require protein unfolding
J. Cell Sci., May 1, 2004; 117(9): 1727 - 1736.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Schafer, H. Zentgraf, C. Zehe, B. Brugger, J. Bernhagen, and W. Nickel
Unconventional Secretion of Fibroblast Growth Factor 2 Is Mediated by Direct Translocation across the Plasma Membrane of Mammalian Cells
J. Biol. Chem., February 20, 2004; 279(8): 6244 - 6251.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Taverna, G. Ghersi, A. Ginestra, S. Rigogliuso, S. Pecorella, G. Alaimo, F. Saladino, V. Dolo, P. Dell'Era, A. Pavan, et al.
Shedding of Membrane Vesicles Mediates Fibroblast Growth Factor-2 Release from Cells
J. Biol. Chem., December 19, 2003; 278(51): 51911 - 51919.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
I. Prudovsky, A. Mandinova, R. Soldi, C. Bagala, I. Graziani, M. Landriscina, F. Tarantini, M. Duarte, S. Bellum, H. Doherty, et al.
The non-classical export routes: FGF1 and IL-1{alpha} point the way
J. Cell Sci., December 15, 2003; 116(24): 4871 - 4881.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
C. Seelenmeyer, S. Wegehingel, J. Lechner, and W. Nickel
The cancer antigen CA125 represents a novel counter receptor for galectin-1
J. Cell Sci., April 1, 2003; 116(7): 1305 - 1318.
[Abstract] [Full Text] [PDF]




© The Company of Biologists Ltd 2002